Constipation, a common gastrointestinal disorder, often presents a diagnostic and therapeutic challenge. This article aims to elucidate a comprehensive approach to its diagnosis and treatment, enabling physicians to effectively manage this condition.
Diagnosis primarily relies on patients' symptoms, with Rome IV criteria being the standard. However, it's crucial to consider differential diagnoses, including irritable bowel syndrome and opioid-induced constipation. A thorough medical history, physical examination, and, if necessary, additional diagnostic tests such as colonoscopy or transit studies can help rule out secondary causes.
First-line treatment typically involves lifestyle modifications and over-the-counter remedies. Dietary changes, such as increasing fiber and fluid intake, can significantly improve symptoms. Osmotic laxatives are often effective, while stimulant laxatives are reserved for short-term use.
For patients unresponsive to first-line treatment, second-line options include prescription drugs such as lubiprostone, linaclotide, and plecanatide. These agents work by increasing intestinal fluid secretion and accelerating transit, thereby alleviating constipation. However, they may cause side effects like diarrhea and abdominal pain.
In refractory cases, biofeedback therapy or surgical intervention may be considered. Biofeedback is particularly beneficial for patients with dyssynergic defecation. Surgery, while rarely used, is an option for severe cases of slow-transit constipation or rectal prolapse.
Understanding constipation's complexity and adopting a comprehensive approach to its diagnosis and treatment is essential for effective patient management. By tailoring the approach to individual patient needs, physicians can significantly improve their patients' quality of life and reduce the burden of this common condition.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation